Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.7150 (35.11%) ($7.7150 - $7.7150) on Mon. Jan. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.5% (three month average) | RSI | 84 | Latest Price | $7.7150(35.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 10.5% a day on average for past five trading days. | Weekly Trend | CAPR advances 23.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) CEMB(79%) TLT(70%) EMHY(57%) FXI(54%) MCHI(53%) | Factors Impacting CAPR price | CAPR will decline at least -3.25% in a week (0% probabilities). XRT(-16%) TBT(-34%) UUP(-20%) USO(-6%) VXX(-23%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.25% (StdDev 6.5%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.89(30.98%) | 10 Day Moving Average | $5.33(44.75%) | 20 Day Moving Average | $4.61(67.35%) | To recent high | 0% | To recent low | 47% | Market Cap | $152m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |